Dulude H, Salvador R, Gallant G
Medicinal Chemistry Laboratory, Faculty of Pharmacy, University of Montreal, Quebec, Canada.
Anticancer Res. 1995 May-Jun;15(3):853-8.
The in vitro cytotoxicity and differential cellular sensitivity of a series of new N1-methyl, N1-allyl, N1-2-chloroethyl and N1-propargyl nitrosourea derivatives of diamino acids were determined in the National Cancer Institute's primary antitumor drug screen. The compounds tested showed an in vitro anticancer activity similar to commercialized nitrosoureas such as CCNU, BCNU, MeCCNU, chlorozotocin, streptozotocin and PCNU. The alkylating moiety of the nitrosoureas seems to play a role in the general selectivity of our compounds. The N1-methyl and N1-2-chloroethyl nitrosourea derivatives are more selective for central nervous system cell lines, the N1-allyl nitrosourea derivatives are more selective for lung cancer cell lines and the N1-propargyl nitrosoureas are more selective for leukemia cell lines.
在国立癌症研究所的原发性抗肿瘤药物筛选中,测定了一系列新型二氨基酸的N1-甲基、N1-烯丙基、N1-2-氯乙基和N1-炔丙基亚硝基脲衍生物的体外细胞毒性和细胞敏感性差异。所测试的化合物显示出与商业化亚硝基脲如洛莫司汀、卡莫司汀、司莫司汀、氯脲菌素、链脲佐菌素和匹莫司汀相似的体外抗癌活性。亚硝基脲的烷基化部分似乎在我们化合物的总体选择性中起作用。N1-甲基和N1-2-氯乙基亚硝基脲衍生物对中枢神经系统细胞系更具选择性,N1-烯丙基亚硝基脲衍生物对肺癌细胞系更具选择性,而N1-炔丙基亚硝基脲对白血病细胞系更具选择性。